DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 30 filers reported holding DOVA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $103,658,000 | +106.9% | 3,708,705 | +4.4% | 2.79% | +142.9% |
| Q2 2019 | $50,098,000 | +80.3% | 3,553,060 | +13.7% | 1.15% | +46.7% |
| Q1 2019 | $27,788,000 | +17.3% | 3,125,851 | 0.0% | 0.78% | -13.1% |
| Q4 2018 | $23,693,000 | -63.9% | 3,125,851 | 0.0% | 0.90% | -48.5% |
| Q3 2018 | $65,549,000 | -29.9% | 3,125,851 | 0.0% | 1.75% | -28.5% |
| Q2 2018 | $93,525,000 | +24.0% | 3,125,851 | +12.4% | 2.45% | +16.1% |
| Q1 2018 | $75,420,000 | +44.8% | 2,780,977 | +53.7% | 2.11% | +22.3% |
| Q4 2017 | $52,099,000 | -38.8% | 1,809,015 | -48.4% | 1.73% | +6.2% |
| Q3 2017 | $85,174,000 | +123.9% | 3,508,030 | +105.6% | 1.63% | -15.0% |
| Q2 2017 | $38,037,000 | – | 1,706,499 | – | 1.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,125,851 | $23,693,000 | 0.90% |
| Broadfin Capital, LLC | 351,800 | $2,667,000 | 0.35% |
| Birchview Capital, LP | 40,000 | $303,000 | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 185,000 | $1,402,000 | 0.16% |
| Fosun International Ltd | 261,780 | $1,984,000 | 0.12% |
| Spark Investment Management LLC | 61,100 | $463,000 | 0.03% |
| Candriam S.C.A. | 233,200 | $1,768,000 | 0.03% |
| GW&K Investment Management, LLC | 178,536 | $1,353,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 20,613 | $156,000 | 0.01% |
| Point72 Hong Kong Ltd | 1,456 | $11,000 | 0.01% |